Skip to main content

Retrospective analysis of biochemical markers in COVID-19 intensive care unit patients



The aim of the study was to evaluate the presence and effects of hematological and biological parameters in the diagnosis of the disease by performing blood tests on COVID-19 patients admitted to the intensive care unit (ICU).


Biochemical parameters from the blood samples of 279 patients who were confirmed to have COVID-19 and met the criteria for admission to the ICU were compared between discharged and deceased patients. Multiple logistic regression analysis was performed in terms of mortality and probability of being discharged. The predictive value of serum C-reactive protein (CRP), procalcitonin (PCT), lymphocyte, neutrophil, leucocyte, and platelet (PLT) levels was evaluated by measuring the area under the receiver operating characteristic curve (AUROC).

Comparisons made according to deceased and survival patients results revealed that while no statistically significant difference was observed between test groups lymphocyte and platelet-lymphocyte ratio values, statistically significant difference was found between the test groups regarding platelet, leukocyte, neutrophil, PCT, neutrophil-lymphocyte ratio (NLR), and thrombocyte count × neutrophil count/lymphocyte count (SII) values.


This study showed that biochemical parameters examined are important in determining the prognosis of the disease and may be useful in determining the direction of the treatment process and predicting the risk of discharge or death after the initial evaluation of the patients in the ICU.


In December 2019, coronavirus disease 2019 (COVID-19) was reported in the Wuhan State of China caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) [1]. During the evolution of the disease, different clinical features and constantly changing laboratory parameters in its prognosis continue to make COVID-19 more deadly. Understanding the relationship between biological processes and clinical outcomes and expanding treatment options for diseases are of great importance, as COVID-19 infection is an epidemic situation that affects very large populations and causes mortality and morbidity. Early detection of inflammatory markers and rapid isolation of SARS-Cov-2 provide support for clinical advances and therapeutic approaches in disease management. Numerous clinical studies published on COVID-19 have focused on the evaluation of patient’s biochemistry and hemogram parameters [2,3,4]. In the course of the COVID-19 disease, biochemical markers play a critical role in the diagnosis, follow-up, and improvement of the treatment development process [5, 6].

In addition, the need for ICU follow-up in COVID-19 patients is planned according to the occupancy rate of the virus, and comorbid causes that will increase the mortality are also important issues [7]. It is thought that the results of the comparative analysis and the interpretation of the biochemical analyses of COVID-19 patients during their stay in the ICU will contribute to the prediction of the progression of the disease, treatment options, the timing of hospitalization, and predicting mortality.

Blood tests have an important role in early diagnosis of the disease, considering the information they provide to physicians regarding the inflammatory process. This information includes leukocyte count and characteristics such as neutrophil- or lymphocyte-dominance, C-reactive protein (CRP), organ damages, and the severity of the disease. Furthermore, biomarkers provide information regarding the nature of pneumonia, meaning that physicians can determine whether a disease is bacterial or due to other etiologies by analyzing blood test results [8]. Included in the complete blood counts (CBC) are values such as leucocytes, neutrophil-lymphocyte ratio (NLR), procalcitonin (PCT), platelet-lymphocyte ratio (PLR) and systemic inflammatory index (SII = thrombocyte count × neutrophil count/lymphocyte count), neutrophil and mean platelet (PLT) volume, and certain ratios of these values. Neutrophils are the most characteristic cell type among the leucocytes and are an important component of the immune system. Regulated by mast cells, epithelial cells, and macrophages, neutrophils also take part in inflammatory processes. The role of lymphocytes in both inflammation and infections is evident. While these parameters may be used as inflammatory markers by themselves, their ratios to one another may also be indicators of early inflammation [9,10,11]. Circulating leukocytes respond to stress by increasing neutrophils and reducing lymphocytes; the ratio of these two parameters is also used as an inflammatory marker [12].

The aim of the study was to evaluate the impact of the most appropriate hematological and biological parameters on the severity of COVID-19.


Study design

Two-hundred seventy-nine COVID-19 patients (confirmed diagnosis with real-time RT-PCR assay), who were hospitalized at the Istanbul Atlas University Medicine Hospital between 6 October 2020 and 6 March 2021 and were consulted for assessment of the need for ICU admission, were collected using the hospital database (Fig. 1). Patient management for COVID-19 was planned according to the guidelines published and updated by the Turkish Ministry of Health [13, 14].

Fig. 1
figure 1

Patient flow of the study

This retrospective study was carried out in line with research regulations, including the approval of the Istanbul Atlas University Local Ethics Committee dated 22 Sep 2021. This study also agrees with the principles of the Declaration of Helsinki of the World Medical Association.

Data collection

Clinical and laboratory findings of these patients during consultation were obtained electronically and evaluated retrospectively. Patients data including age, gender, laboratory parameters obtained from blood samples, and the data obtained as a result of examination and recorded on the hospital database consultation form were analyzed. Respiratory rate ≥ 30 times/min, dyspnea and respiratory distress symptoms, arterial oxygen saturation/oxygen concentration ≤ 300 mmHg, bilateral infiltrates or multilobar involvement on chest computed tomography, thrombocytopenia, organ dysfunctions, the presence of multiple or particularly uncontrolled comorbidity, and troponin elevation are accepted as ICU admission criteria [13].

Evaluation of data

All data were entered twice into a computer using Minitab® 19.2020.1 program fort to double-check to ensure accuracy. The counting data were expressed as multiple regression analyses for detection of dependent and independent variables and estimation of mortality. Binary logistic regression and area under the receiver operating characteristic curve (AUROC) analysis was performed by taking into account all neutrophil, lymphocyte, PLT, CRP, PCT, NLR, and SII variables, which appeared to have an effect. All statistical analyses were performed using IBM SPSS Statistics version 25.0, and findings were considered statistically significant p < 0.05.


A total 279 cases were included in this study, including 178 males and 101 females. Of 178 male patients, 78 (43.8%) died and 100 (56.2%) were discharged. Of 101 female patients, 53 (52.5%) died and 48 (47.5%) were discharged. The mean age of the female and male patients in the study was 67.15 ± 15.4 and 67.25 ± 15.3, respectively. Demographic characteristics of the patients are shown in Table 1. The mean age of the 279 patients who were discharged from the study was 62.5 ± 16.27 years, while the mean age of those who died was 72.4 ± 12.61 (p < 0.005). There were no statistically significant differences between deceased and discharged patients regarding the gender. Among the biochemical parameters, neutrophil, lymphocyte, platelet, CRP, PCT, NLR, and SII were found to be significantly different in the discharged and expired ICU patient groups (Table 2). However, there were no significant difference in leucocyte and PLR parameters between deceased and discharge groups.

Table 1 Demographic characteristics and hospitalization days in ICU patients (n = 279)
Table 2 Laboratory tests of 279 ICU patients with COVID-19

Interpretations are made with the odds, which are the ratio of the probability of being deceased to the probability of being discharged. According to the odds ratio values in Table 3, it was determined that the most important variable in the event of death was neutrophil and age. Age, neutrophil, CRP, NLR, and SII independent variables are observed to be independent risk variables on death due to COVID-19, with OR values of 1.0492, 1.0497, 1.0037, and 1.0365, respectively. Each unit increase of these variables increases the probability of mortality. A one-unit increase in age will increase the probability of an ex event 1.0492 times, provided other variables remain constant. Provided that other variables remain constant, a one-unit increase in neutrophil value will increase the probability of being an ex by 1.0497 times. According to the results in Table 3, it is seen that the SII variable reduces the mortality rate.

Table 3 Age, neutrophil, CRP, NLR, and SII, independent risk variables on death due to COVID-19, with OR

The significance of CRP, PCT, lymphocyte, neutrophil, leucocyte, and platelet values according to ROC analysis was examined; CRP, PCT, lymphocyte, and platelet were found to be statistically significant. Our results showed that age indicator in the deceased group was significantly higher than that in the discharge group. The AUROC of the age predicting the deceased of ICU was the largest. The cutoff age point was 68.5; sensitivity and specificity were 68.7% and 63.9%, respectively. The second largest area of the AUC was NLR. NLR in the deceased group was significantly higher. The AUROC of the NLR predicting the deceased of ICU was the largest hematologic biomarker (Fig. 2, Table 4).

Fig. 2
figure 2

AUC of ROC curve of the CRP, PCT, lymphocyte, neutrophil, leucocyte and platelet values

Table 4 The AUCROC of each independent risk or prediction factors


In the fight against COVID-19 disease, the correct interpretation of biomarkers is very important in terms of diagnosing the severity of the disease, evaluating patient admission criteria, patient care, and standardization of treatment. In general, hematological markers such as CRP and PCT are accepted as important infection biomarkers of severe COVID-19 disease [15]. The rates of marker levels between severe and mild disease groups showed differences in most studies [16, 17]. The significantly higher PCT and CRP values in the ICU patients are related to the severe and adverse progress of COVID-19 [18,19,20]. Obtaining similar results in biochemical parameters in our study was consistent with other studies [21,22,23,24]. Their data showed that COVID-19 might mainly act on lymphocytes, particularly T lymphocytes. NLR was identified as an early risk factor for severe COVID-19, and most patients in the severe group showed higher levels of infection-related indicators such as CRP. In our study, as in other studies, NLR was shown to be important in determining the severity of COVID-19. High levels of NLR may be a strong prognostic indicator for worsening the severity of COVID-19 [25, 26]. Furthermore, Chan et al. in a meta-analysis concluded that NLR and PLR can be served as independent prognostic markers of disease severity in COVID-19 [27]. In our study, neutrophil, lymphocyte, platelet, NLR, PCT, SII, and CRP showed significant difference between survival and deceased groups. There are also some studies showing that T cells are important for the recognition and clearance of infected cells, particularly in the lungs of infected individuals. Thus, pathophysiology of COVID-19 is majorly associated with lymphocytes, especially T lymphocytes exaggerated inflammatory responses during the lung involvement [28, 29]. In this study, when the significance of CRP, PCT, lymphocyte, neutrophil, leucocyte, and platelet values according to ROC analysis was examined, CRP, PCT, lymphocyte, and platelet were found to be statistically significant (p < 0.05). Among the hematological parameters, the most prominent area of the AUCROC was for the CRP and PCT values. For the values here, the diagnostic test is easy to distinguish but difficult to interpret because the areas of the other values are close to the 0.5 line.

In addition, when the relationship of important biomarkers with COVID-19 prognosis in the intensive care stage is interpreted, estimates can be made with data on varying levels and regression analysis. These results can be very helpful in terms of ease of diagnosis and monitoring of response to treatment. SII was found to be significantly higher in deceased patients when compared with survival group, meaning that it can also be used as predictor of COVID-19 severity and outcome. COVID-19 ICU patients were more commonly observed in men than women (64% vs 36%) in our study [30, 31]. Although the age factor was found to be significantly different, the length of stay in the ICU patients did not have a significant effect on discharge or death. In correlation with other studies, no significant difference was found in the gender factor. The most obvious result in our cohort is that the probability of death of patients hospitalized in the ICU is directly related to age, neutrophils, CRP, NLR, and SII. Therefore, early diagnosis and promptly treatment initiation of critically ill individuals is issue of crucial importance.

As demonstrated by several studies [32,33,34,35], our results showed also the NLR in the survival group was significantly higher than non-survival group. Recently, a meta-analysis performed by Lagunas- Rengel [25] showed that the NLR values were found to increase in COVID-19 patients. Our study showed that CRP and neutrophil were significantly higher than that in the deceased group, and CRP and neutrophil were an independent risk factor for COVID-19 ICU patients. Therefore, the detection of CRP levels in ICU patients is of great value in assessing their condition. Our study also showed that SII was lower in the deceased group than survival group. According to univariate regression analysis, neutrophil, lymphocyte, platelet, CRP, NLR and SII biomarkers are variable coefficients that affect the probability of ex. In addition, according to binary logistic regression analysis, SII was found to be an independent protective factor for intensive care patients with COVID-19.

In conclusions, NLR, PCT, CRP, and SII can be considered as prognostic, predictive, or risk-stratifying factors of severe form of COVID-19.

Study limitations

This study has several limitations. One of the limitation was the relatively small sample size and missing of several biochemical parameters. In addition, other variables including concomitant diseases and treatment protocols that are also important during the course of COVID-19 were not determined in this study.



Intensive care unit




C-reactive protein


Neutrophil lymphocyte ratio


Platelet lymphocyte ratio


Systemic inflammatory index [platelet × NLR (per μl)]


  1. Li Q, Guan X, Wu P et al (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382(13):1199–1207

    CAS  Article  Google Scholar 

  2. Yelgeç N, Karataş M, Karabay C, Çanga Y, Çalık A, Şi̇mşek B et al (2020) The relationship between acute renal failure after transcatheter aortic valve replacement and preprocedural neutrophil to lymphocyte ratio. Dicle Tıp Dergisi 47(1):1–9

    Google Scholar 

  3. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, Luo M, Chen L, Zhao Y (2020) Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect 81(1):e6–e12. Epub 2020 Apr 10. PMID: 32283162; PMCID: PMC7195072

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G (2020) Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 58(7):1021–1028

    CAS  Article  Google Scholar 

  5. Yufei Y, Mingli L, Xuejiao L, Xuemai D, Yiming J, Qin Q et al (2020) Utility of the neutrophil-to-lymphocyte ratio and Creactive protein level for coronavirus disease 2019 (COVID-19). Scand J Clin Lab Invest 80(7):536–540

    CAS  Article  Google Scholar 

  6. Budak F, Korkmaz Ş (2020) COVID-19. An overall evaluation for the COVID-19 pandemic process: the case of Turkey. J of Soc Sci Manag 1(1):62–79

    Google Scholar 

  7. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID19) Available from: Accessed Nov 2021.

  8. Bekdas M, Goksugur SB, Sarac EG, Erkocoglu M, Demircioglu F (2014) Neutrophil/lymphocyte and C-reactive protein/mean platelet volume ratios in differentiating between viral and bacterial pneumonias and diagnosing early complications in children. Saudi Med J 35(5):442–447

    PubMed  Google Scholar 

  9. Ilhan M, Ilhan G, Gok AF, Bademler S, Atmaca F, Ertekin C (2016) Evaluation of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and red blood cell distribution width-platelet ratio as early predictor of acute pancreatitis in pregnancy. J Matern Fetal Neonatal Med 29(9):1476–1480

    CAS  Article  Google Scholar 

  10. Yazar FM, Bakacak M, Emre A et al (2015) Predictive role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for diagnosis of acute appendicitis during pregnancy. Kaohsiung J Med Sci 31(11):591–596

    Article  Google Scholar 

  11. Liu J, Li S, Zhang S et al (2019) Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. J Clin Lab Anal 33(8):e22964

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Xiang N, Havers F, Chen T et al (2013) Use of national pneumonia surveillance to describe influenza A (H7N9) virus epidemiology, China. Emerg Infect Dis 19(11):1784–1790

    Article  Google Scholar 

  13. Republic of Turkey Ministry of Health, Directorate General of Public Health COVID-19 (SARS-CoV-2 infection) guide: COVID-19 adult patient management and treatment. Ankara: Republic of Turkey, Ministry of Health; 2020. Available from: Tedavisi.pdf [Last ].

  14. Republic of Turkey Ministry of Health, Directorate General of Public Health COVID-19 (SARS-CoV-2 infection) guide: study of scientific board (online). Ankara: Republic of Turkey, Ministry of Health; 2020. Available from: uploads/2020/04/COVID-19_Rehberi-2.pdf [Last ].

  15. Zhang JJ, Dong X, Cao YY et al (2020) Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 75:1730–1741

    CAS  Article  Google Scholar 

  16. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513

    CAS  Article  Google Scholar 

  17. Lippi G, Plebani M (2020) Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 58:1131–1134

    CAS  Article  Google Scholar 

  18. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506

    CAS  Article  Google Scholar 

  19. Wang L (2020) C-reactive protein levels in the early stage of COVID-19. Med Mal Infect 50(4):332–334

    CAS  Article  Google Scholar 

  20. Asghar MS et al (2020) Poor prognostic biochemical markers predicting fatalities caused by COVID-19: a retrospective observational study from a developing country. Cureus 12(8):e9575

    PubMed  PubMed Central  Google Scholar 

  21. Siordia JA Jr (2020) Epidemiology and clinical features of COVID-19: a review of current literature. J Clin Virol 127:104357

    CAS  Article  Google Scholar 

  22. Kong M, Zhang H, Cao X, Mao X, Lu Z (2020) Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19. Epidemiol Infect 148:e139

    Article  Google Scholar 

  23. Yan X, Li F, Wang X, Yan J, Zhu F, Tang S et al (2019) Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: a retrospective cross-sectional study. J Med Virol 92:2573–2581.

    CAS  Article  Google Scholar 

  24. Ma A, Cheng J, Yang J, Dong M, Liao X, Kang Y (2020) Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients. Crit Care 24:288.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Lagunas-Rangel FA (2020) Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. J Med Virol 92:1733–1734.

    CAS  Article  PubMed  Google Scholar 

  26. Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B (2020) C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis 14:1753466620937175.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  27. Chan AS, Rout A (2020) Use of neutrophil-to-lymphocyte and platelet-tolymphocyte ratios in COVID-19. J Clin Med Res 12(7):448

    CAS  Article  Google Scholar 

  28. Liu WJ, Zhao M, Liu K, Xu K, Wong G, Tan W, Gao GF (2017) T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV. Antiviral Res 137:82–92

    CAS  Article  Google Scholar 

  29. Gu J et al (2005) Multiple organ infection and the pathogenesis of SARS. J Exp Med 202(3):415–424

    CAS  Article  Google Scholar 

  30. Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S (2017) Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J Immunol 198(10):4046–4053

    CAS  Article  Google Scholar 

  31. Badawi A, Ryoo SG (2016) Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis 49:129–133

    Article  Google Scholar 

  32. Han Q, Wen X, Wang L et al (2020) Role of hematological parameters in the diagnosis of influenza virus infection in patients with respiratory tract infection symptoms. J Clin Lab Anal 34(5):e23191

    CAS  Article  Google Scholar 

  33. Bao X, Zhou G, Xu W, Liu X, Ye Z, Jiang F (2020) Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio: novel markers for the diagnosis and prognosis in patients with restenosis following CAS. Biomark Med 14:271–282

    CAS  Article  Google Scholar 

  34. Zhang Y, Zou P, Gao H et al (2019) Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study. Ther Clin Risk Manag 15:911–919

    CAS  Article  Google Scholar 

  35. Tanrıverdi H, Örnek T, Erboy F et al (2015) Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD. Wien Klin Wochenschr 127(19-20):756–763

    Article  Google Scholar 

Download references


This work was not supported by any funding.

Author information

Authors and Affiliations



The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Sema Ketenci.

Ethics declarations

Ethics approval and consent to participate

The study conforms to the ethical standards of the Helsinki Declaration, and approval was obtained from the Istanbul Atlas Unıversity ethic committee. E-22686390-050.01.04-8481.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ketenci, S., Saraçoğlu, İ., Duranay, R. et al. Retrospective analysis of biochemical markers in COVID-19 intensive care unit patients. Egypt J Bronchol 16, 27 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • COVID-19
  • Biomarkers
  • Intensive care unit
  • Biochemical parameters